| Pacific Biomarkers Awarded Major Research Contract as Part of Phase I Cardiovascular Program (PR Newswire) Pacific Biomarkers, Inc. has been awarded a contract by a leading multinational pharmaceutical company to provide essential laboratory data for an adaptive Phase I cardiovascular trial. us.rd.yahoo.com |
Investors Consider Biotech's Latest Results The Burrill Report submits: Earnings season is well underway with Gilead (GILD), Genzyme (GENZ), Biogen Idec, and Roche (RHHBY.PK) all having reported their second quarter results. The numbers have been a mixed bag and there are some big questions overhanging key players in the industry. Some investors are looking beyond the quarter, but what they see isn’t always encouraging. We spoke to Adam Feuerstein, senior columnist for The Street.com, about how the second quarter numbers are shaping up, what red flags may be out there, and how investors are looking at the results these days.Complete Story » seekingalpha.com |
Penwest Deal Frees Endo From Royalty Payments, Expands Drug Portfolio The Burrill Report submits: By Michael FitzhughEndo Pharmaceuticals (ENDP) has launched a $168 million bid to buy Penwest Pharmaceutical (PPCO), a purchase that could slash Endo's expenses and expand its rare disease portfolio. The two companies have collaborated since 1997 on the development and commercialization of Opana ER, a long-acting pain medication that incorporates Penwest's proprietary controlled-release drug delivery system TimerX. Once Endo owns Penwest, it can quit paying royalties to the company. Complete Story » seekingalpha.com |
U.K. Reverses Stance On Alzheimer's Drugs The U.K.'s health-care costs watchdog said it aims to lift limits on the use of four Alzheimer's drugs by the state-funded National Health Service, a move that could benefit hundreds of thousands of people. online.wsj.com |
Glaxo to Pay $750 Million in Pact Glaxo agreed to pay $750 million and plead guilty to a criminal charge to settle a U.S. government investigation of manufacturing deficiencies at its former plant in Puerto Rico. online.wsj.com |